Halozyme Therapeutics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2012 | $29.7M | $48.9M | $99.5M |
| FY2013 | $49.8M | $-20.0M | $27.4M |
| FY2014 | $49.9M | $41.4M | $61.4M |
| FY2015 | $28.0M | $43.0M | $43.3M |
| FY2016 | $199.2M | $-32.5M | $66.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2012 | $29.7M | $48.9M | $99.5M |
| FY2013 | $49.8M | $-20.0M | $27.4M |
| FY2014 | $49.9M | $41.4M | $61.4M |
| FY2015 | $28.0M | $43.0M | $43.3M |
| FY2016 | $199.2M | $-32.5M | $66.8M |